GROUPE BRUXELLES LAMBERT NV (GBLB.BR) Fundamental Analysis & Valuation

EBR:GBLB • BE0003797140

Current stock price

80.8 EUR
+0.1 (+0.12%)
Last:

This GBLB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. GBLB.BR Profitability Analysis

1.1 Basic Checks

  • GBLB had negative earnings in the past year.
  • In the past year GBLB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: GBLB reported negative net income in multiple years.
  • In the past 5 years GBLB always reported a positive cash flow from operatings.
GBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFGBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

1.2 Ratios

  • GBLB has a Return On Assets of -2.52%. This is in the lower half of the industry: GBLB underperforms 73.68% of its industry peers.
  • Looking at the Return On Equity, with a value of -5.40%, GBLB is doing worse than 68.42% of the companies in the same industry.
  • With a Return On Invested Capital value of 0.59%, GBLB is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.52%
ROE -5.4%
ROIC 0.59%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GBLB.BR Yearly ROA, ROE, ROICGBLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • GBLB has a Operating Margin of 2.75%. This is in the lower half of the industry: GBLB underperforms 64.91% of its industry peers.
  • In the last couple of years the Operating Margin of GBLB has declined.
  • GBLB has a Gross Margin of 66.91%. This is in the better half of the industry: GBLB outperforms 64.91% of its industry peers.
  • GBLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.75%
PM (TTM) N/A
GM 66.91%
OM growth 3Y44.11%
OM growth 5Y-27.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.62%
GM growth 5Y-1.58%
GBLB.BR Yearly Profit, Operating, Gross MarginsGBLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GBLB.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBLB is destroying value.
  • GBLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GBLB.BR Yearly Shares OutstandingGBLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GBLB.BR Yearly Total Debt VS Total AssetsGBLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 1.38, we must say that GBLB is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.38, GBLB is in line with its industry, outperforming 56.14% of the companies in the same industry.
  • GBLB has a debt to FCF ratio of 112.05. This is a negative value and a sign of low solvency as GBLB would need 112.05 years to pay back of all of its debts.
  • GBLB has a Debt to FCF ratio of 112.05. This is in the lower half of the industry: GBLB underperforms 68.42% of its industry peers.
  • A Debt/Equity ratio of 0.60 indicates that GBLB is somewhat dependend on debt financing.
  • The Debt to Equity ratio of GBLB (0.60) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 112.05
Altman-Z 1.38
ROIC/WACC0.08
WACC7.32%
GBLB.BR Yearly LT Debt VS Equity VS FCFGBLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • GBLB has a Current Ratio of 2.66. This indicates that GBLB is financially healthy and has no problem in meeting its short term obligations.
  • GBLB's Current ratio of 2.66 is fine compared to the rest of the industry. GBLB outperforms 77.19% of its industry peers.
  • A Quick Ratio of 2.27 indicates that GBLB has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 2.27, GBLB is doing good in the industry, outperforming 77.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 2.27
GBLB.BR Yearly Current Assets VS Current LiabilitesGBLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. GBLB.BR Growth Analysis

3.1 Past

  • The earnings per share for GBLB have decreased strongly by -614.58% in the last year.
  • The Revenue has decreased by -5.21% in the past year.
  • Measured over the past years, GBLB shows a decrease in Revenue. The Revenue has been decreasing by -0.95% on average per year.
EPS 1Y (TTM)-614.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-402.31%
Revenue 1Y (TTM)-5.21%
Revenue growth 3Y5.02%
Revenue growth 5Y-0.95%
Sales Q2Q%-5.32%

3.2 Future

  • The Earnings Per Share is expected to decrease by -1.44% on average over the next years.
  • GBLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.25% yearly.
EPS Next Y-20.89%
EPS Next 2Y-1.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.79%
Revenue Next 2Y4.25%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GBLB.BR Yearly Revenue VS EstimatesGBLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
GBLB.BR Yearly EPS VS EstimatesGBLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

1

4. GBLB.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • GBLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 29.08, GBLB can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GBLB indicates a slightly more expensive valuation: GBLB is more expensive than 64.91% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of GBLB to the average of the S&P500 Index (38.18), we can say GBLB is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 29.08
GBLB.BR Price Earnings VS Forward Price EarningsGBLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as GBLB.
  • Based on the Price/Free Cash Flow ratio, GBLB is valued a bit more expensive than the industry average as 68.42% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 156.21
EV/EBITDA 15.07
GBLB.BR Per share dataGBLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.44%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. GBLB.BR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.46%, GBLB is a good candidate for dividend investing.
  • GBLB's Dividend Yield is a higher than the industry average which is at 2.34.
  • GBLB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.46%

5.2 History

  • The dividend of GBLB decreases each year by -2.00%.
Dividend Growth(5Y)-2%
Div Incr Years2
Div Non Decr Years5
GBLB.BR Yearly Dividends per shareGBLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

5.3 Sustainability

  • GBLB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The Dividend Rate of GBLB has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-99.04%
EPS Next 2Y-1.44%
EPS Next 3YN/A
GBLB.BR Yearly Income VS Free CF VS DividendGBLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

More info and screens

Find the best dividend stocksShow peers with best dividend

GBLB.BR Fundamentals: All Metrics, Ratios and Statistics

GROUPE BRUXELLES LAMBERT NV

EBR:GBLB (4/14/2026, 7:00:00 PM)

80.8

+0.1 (+0.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-12
Earnings (Next)05-07
Inst Owners25.38%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap10.76B
Revenue(TTM)6.34B
Net Income(TTM)-625.40M
Analysts84.29
Price Target87.85 (8.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.46%
Yearly Dividend2.78
Dividend Growth(5Y)-2%
DP-99.04%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.01%
PT rev (3m)3.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.99%
EPS NY rev (3m)-19.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.54%
Revenue NY rev (3m)1.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 29.08
P/S 1.7
P/FCF 156.21
P/OCF 14.41
P/B 0.93
P/tB 2.28
EV/EBITDA 15.07
EPS(TTM)-4.94
EYN/A
EPS(NY)2.78
Fwd EY3.44%
FCF(TTM)0.52
FCFY0.64%
OCF(TTM)5.61
OCFY6.94%
SpS47.57
BVpS86.9
TBVpS35.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.52%
ROE -5.4%
ROCE 0.79%
ROIC 0.59%
ROICexc 0.72%
ROICexgc 1.16%
OM 2.75%
PM (TTM) N/A
GM 66.91%
FCFM 1.09%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y44.11%
OM growth 5Y-27.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.62%
GM growth 5Y-1.58%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 112.05
Debt/EBITDA 8.71
Cap/Depr 109.53%
Cap/Sales 10.7%
Interest Coverage 0.57
Cash Conversion 94.19%
Profit Quality N/A
Current Ratio 2.66
Quick Ratio 2.27
Altman-Z 1.38
F-Score5
WACC7.32%
ROIC/WACC0.08
Cap/Depr(3y)102.89%
Cap/Depr(5y)96.5%
Cap/Sales(3y)9.69%
Cap/Sales(5y)9.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-614.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-402.31%
EPS Next Y-20.89%
EPS Next 2Y-1.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.21%
Revenue growth 3Y5.02%
Revenue growth 5Y-0.95%
Sales Q2Q%-5.32%
Revenue Next Year3.79%
Revenue Next 2Y4.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.63%
EBIT growth 3Y51.34%
EBIT growth 5Y-27.99%
EBIT Next Year309.9%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.78%
FCF growth 3Y-27.94%
FCF growth 5Y-39.77%
OCF growth 1Y-43.8%
OCF growth 3Y-3.04%
OCF growth 5Y-9.49%

GROUPE BRUXELLES LAMBERT NV / GBLB.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GBLB.BR.


Can you provide the valuation status for GROUPE BRUXELLES LAMBERT NV?

ChartMill assigns a valuation rating of 1 / 10 to GROUPE BRUXELLES LAMBERT NV (GBLB.BR). This can be considered as Overvalued.


How profitable is GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

GROUPE BRUXELLES LAMBERT NV (GBLB.BR) has a profitability rating of 2 / 10.


How financially healthy is GROUPE BRUXELLES LAMBERT NV?

The financial health rating of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) is 4 / 10.